Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply |
| |
| Authors: | Ian Roberts Haleema Shakur |
| |
| Institution: | 1. Trials Co-ordinating Centre, London School of Hygiene & Tropical Medicine, Keppel St, WC1E 7HT, London, UK
|
| |
| Abstract: | A response to the letter regarding The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Mr Vincent Simmon President and CEO of Xytis Inc. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
